We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spectra Systems Corporation | LSE:SPSY | London | Ordinary Share | COM SHS USD0.01 (UNRES) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.90% | 221.00 | 216.00 | 226.00 | 223.00 | 221.00 | 223.00 | 21,980 | 12:21:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 19.63M | 6.15M | 0.1364 | 19.06 | 117.15M |
TIDMSPSY TIDMSPSC
RNS Number : 7203O
Spectra Systems Corporation
14 June 2022
Spectra Systems Corporation
("The Company" or "Spectra Systems")
Appointment of Chief Financial Officer
Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software is delighted to announce that it has agreed to appoint Colleen Hamill, C.P.A. (aged 56) as its new Chief Financial Officer.
Colleen Hamill started her career in 1987 at KPMG Peat Marwick in public accounting prior to working as an Accounting Manager at HMK Enterprises, Inc. an $820MM diversified holding company from 1990 to 1996. From 1996 to 2007, Ms. Hamill was the Global Corporate Controller and a member of the senior management at Brewster Wallcovering, a global distributer and manufacturer of wall covering and related products. Following this position, she held the position of Senior Director of Corporate Accounting at GTECH (now IGT) for eight months before moving to the position of Senior Manager for Financial Reporting at Brookfield Renewable Power, a $12B operator and developer of hydroelectric power facilities. From 2010 to 2015, Ms. Hamill was the Global Manager for consolidations at Covidien, a $10B medical devices company. From this position, she has worked as the Finance Leader in the US operations of Boston-Power, a venture capital-backed developer and manufacturer of lithium-ion batteries and most recently as the Global Controller at Harvard Biosciences.
This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
Colleen Hamill has confirmed that there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.
Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Colleen to Spectra Systems and believe that her extensive financial experience, particularly in technology driven companies will be of immense value to us."
Enquiries:
Spectra Systems Corporation Tel: +1 (0)401 274 4700 Dr. Nabil Lawandy, Chief Executive Officer WH Ireland Limited (Nominated Adviser Tel: +44 (0)20 7220 1650 and Broker) Chris Fielding (Head of Corporate Finance) Andrew de Andrade (Executive, Corporate Finance) Tel: +44 (0)20 3328 5665 Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate Finance) Amrit Nahal (Sales and Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCSFMFADEESEFM
(END) Dow Jones Newswires
June 14, 2022 02:00 ET (06:00 GMT)
1 Year Spectra Systems Chart |
1 Month Spectra Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions